TG Therapeutics Inc.(TGTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TGTX TG Therapeutics Inc.

交易中 11-22 09:37:00 EST

34.33

-0.22

-0.62%

最高34.60	最低34.09	成交量7.97万
今开34.60	昨收34.55	日振幅1.48%
总市值53.45亿	流通市值50.13亿	总股本1.56亿
成交额274.00万	换手率0.05%	流通股本1.46亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TGTX","market":"US","secType":"STK","nameCN":"TG Therapeutics Inc.","latestPrice":34.3344,"timestamp":1732286218650,"preClose":34.55,"halted":0,"volume":79694,"delay":0,"floatShares":146000000,"shares":155665334,"eps":0.639101,"marketStatus":"交易中","marketStatusCode":2,"change":-0.2156,"latestTime":"11-22 09:37:00 EST","open":34.6,"high":34.6,"low":34.09,"amount":2739962.60176,"amplitude":0.014761,"askPrice":34.47,"askSize":170,"bidPrice":34.23,"bidSize":200,"shortable":3,"etf":0,"ttmEps":0.639101,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732309200000},"adr":0,"listingDate":1128657600000,"adjPreClose":34.55,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":34.63,"preClose":34.55,"latestTime":"09:29 EST","volume":4304,"amount":149537.844592,"timestamp":1732285799924},"postHourTrading":{"tag":"盘后","latestPrice":34.74,"preClose":34.55,"latestTime":"19:56 EST","volume":222168,"amount":7660309.1598,"timestamp":1732236960300},"volumeRatio":1.090411,"impliedVol":0.7672,"impliedVolPercentile":0.3889},"requestUrl":"/m/hq/s/TGTX","defaultTab":"news","newsList":[{"id":"2483839116","title":"Tg Therapeutics, Inc.盘中异动 早盘快速拉升5.65%报32.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483839116","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483839116?lang=zh_cn&edition=full","pubTime":"2024-11-14 00:28","pubTimestamp":1731515300,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日00时28分，Tg Therapeutics, Inc.股票出现异动，股价大幅上涨5.65%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114002820971a6568&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114002820971a6568&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","TGTX","LENZ","BK4585"],"gpt_icon":0},{"id":"1181694956","title":"异动解读 | TG Therapeutics Inc.股价大涨5.28% 业绩和产品线发展或为推手","url":"https://stock-news.laohu8.com/highlight/detail?id=1181694956","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181694956?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:56","pubTimestamp":1731336994,"startTime":"0","endTime":"0","summary":"TG Therapeutics Inc.公司今日盘中股价大涨5.28%,引发市场关注。公司近期没有重大利好消息公布,但从公司最新财报和产品线情况来看,可能是股价上涨的推手。另外,公司旗舰产品BRIUMVI已获FDA批准用于治疗复发性多发性硬化症,且公司在B细胞疾病领域还有潜在产品线在开发。如果新药研发取得进展,将为公司带来长期增长动力。因此,良好的业绩表现和产品线发展可能是推动股价上涨的主因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | TG Therapeutics Inc.股价大涨5.28% 业绩和产品线发展或为推手","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TGTX"],"gpt_icon":0},{"id":"2482773872","title":"Tg Therapeutics, Inc.盘中异动 股价大涨5.14%报30.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482773872","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482773872?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:38","pubTimestamp":1731335928,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时38分，Tg Therapeutics, Inc.股票出现波动，股价大幅拉升5.14%。截至发稿，该股报30.29美元/股，成交量30.44万股，换手率0.20%，振幅3.02%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223848971a5b3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223848971a5b3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LENZ","TGTX","BK4588","BK4139"],"gpt_icon":0},{"id":"2482076374","title":"Tg Therapeutics, Inc.2024财年第三财季实现净利润3.88百万美元，同比减少96.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482076374","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482076374?lang=zh_cn&edition=full","pubTime":"2024-11-10 08:02","pubTimestamp":1731196941,"startTime":"0","endTime":"0","summary":"11月10日，Tg Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为3.88百万美元，同比减少96.60%；其中营业收入为83.88百万美元，同比减少49.47%，每股基本收益为0.03美元。机构评级：截至2024年11月10日，当前有9家机构对Tg Therapeutics, Inc.目标价做出预测，其中目标均价为37.22美元，其中最低目标价为9.00美元，最高目标价为55.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110080231abb1a2e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110080231abb1a2e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TGTX","LENZ"],"gpt_icon":0},{"id":"1155261775","title":"异动解读 | TGTX财报营收利润双双暴跌 市场担忧致盘前重挫19%","url":"https://stock-news.laohu8.com/highlight/detail?id=1155261775","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155261775?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:24","pubTimestamp":1730733889,"startTime":"0","endTime":"0","summary":"生物制药公司TG Therapeutics Inc.2024年第三季度业绩公布后,盘前股价遭到重挫,暴跌19%。财报显示,TGTX第三季度营收同比大跌近50%,仅为8388万美元,远低于分析师预期的8171万美元。业绩低于预期令投资者信心受挫,纷纷抛售股票避险,导致TGTX当日开盘便大幅低开,随后一路大跌,从28.26美元/股直线下探至24.26美元/股,下跌幅度一度超过18.66%。截至北京时间11月4日晚上22时30分,TGTX股价报收于24.26美元/股,跌幅9.81%,全日成交量达99.4万股,换手率0.64%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TGTX"],"gpt_icon":0},{"id":"2480354587","title":"TG Therapeutics Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2480354587","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480354587?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:20","pubTimestamp":1730733619,"startTime":"0","endTime":"0","summary":"   * TG Therapeutics Inc   报告了截至9月30日的季度调整后每股收益2美分，低于去年同期的每股收益73美分。八位分析师对该季度的平均预期是每股收益 3 美分。华尔街预期为每股收益-5 美分至 8 美分。* 营收为 8388 万美元，同比下降 49.4%；分析师预期为 8171 万美元。* TG Therapeutics 公司公布的本季度每股收益为 2 美分。* 公司报告的季度净收入为 388 万美元。* TG Therapeutics Inc 的股价本季度上涨了 15.0%，今年迄今为止上涨了 57.5%。华尔街对 TG Therapeutics Inc 的 12 个月目标价中位数为 41.50 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","TG","BK4585","BK4153","BK4090","LENZ","BK4139","TGTX"],"gpt_icon":0},{"id":"2480581435","title":"Tg Therapeutics, Inc.盘中异动 股价大跌9.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480581435","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480581435?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:31","pubTimestamp":1730730716,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时31分，Tg Therapeutics, Inc.股票出现异动，股价快速跳水9.81%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Briacell Therapeutics Corp C/Wts 24/02/2025、Disc Medicine, Inc.、Nls Pharmaceutics Ltd.涨幅较大，Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃，换手率分别为233.88%、126.46%、41.13%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025、Nls Pharmaceutics Ltd.、Tenaya Therapeutics, Inc.，振幅分别为29.83%、11.39%、9.28%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422315795bdc9c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422315795bdc9c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","BK4588","LENZ","TGTX"],"gpt_icon":0},{"id":"2480188435","title":"Tg Therapeutics, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480188435","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480188435?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:58","pubTimestamp":1730469535,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日21时58分，Tg Therapeutics, Inc.股票出现波动，股价急速上涨5.03%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101215855971a3dda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101215855971a3dda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TGTX","LENZ","BK4139","BK4588","BK4585"],"gpt_icon":0},{"id":"2474400239","title":"Tg Therapeutics, Inc.盘中异动 下午盘股价大涨5.08%报22.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474400239","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474400239?lang=zh_cn&edition=full","pubTime":"2024-10-09 03:13","pubTimestamp":1728414798,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日03时13分，Tg Therapeutics, Inc.股票出现异动，股价大幅上涨5.08%。截至发稿，该股报22.39美元/股，成交量118.065万股，换手率0.76%，振幅5.58%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410090313199719f07d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410090313199719f07d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","TGTX","BK4585","BK4588"],"gpt_icon":0},{"id":"2469147531","title":"Tg Therapeutics, Inc.盘中异动 股价大跌5.07%报23.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469147531","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469147531?lang=zh_cn&edition=full","pubTime":"2024-09-24 00:42","pubTimestamp":1727109721,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日00时42分，Tg Therapeutics, Inc.股票出现波动，股价急速下挫5.07%。截至发稿，该股报23.40美元/股，成交量131.948万股，换手率0.85%，振幅5.52%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.72%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924004202ab656237&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924004202ab656237&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TGTX","BK4139","BK4588","LENZ","BK4585"],"gpt_icon":0},{"id":"2468462165","title":"Tg Therapeutics, Inc.盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468462165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468462165?lang=zh_cn&edition=full","pubTime":"2024-09-20 22:13","pubTimestamp":1726841593,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日22时13分，Tg Therapeutics, Inc.股票出现波动，股价快速下跌5.02%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.06%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920221313a1db75b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920221313a1db75b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","TGTX","BK4588","BK4585"],"gpt_icon":0},{"id":"2460444262","title":"Tg Therapeutics, Inc.盘中异动 股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460444262","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460444262?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:38","pubTimestamp":1723826293,"startTime":"0","endTime":"0","summary":"北京时间2024年08月17日00时38分，Tg Therapeutics, Inc.股票出现波动，股价快速拉升5.11%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Cingulate Inc.、Geovax Labs, Inc.涨幅较大，Cingulate Inc.、Seelos Therapeutics, Inc.、Geovax Labs, Inc.较为活跃，换手率分别为8080.83%、1950.65%、1078.15%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Cingulate Inc.、Geovax Labs, Inc.，振幅分别为259.26%、176.25%、69.25%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081700381398e3533b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081700381398e3533b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","BK4585","TGTX","LENZ"],"gpt_icon":0},{"id":"2459727314","title":"Tg Therapeutics, Inc.2024财年第二财季实现净利润6.88百万美元，同比增加114.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459727314","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459727314?lang=zh_cn&edition=full","pubTime":"2024-08-16 00:01","pubTimestamp":1723737687,"startTime":"0","endTime":"0","summary":"8月16日，Tg Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为6.88百万美元，同比增加114.45%；其中营业收入为73.47百万美元，同比增加357.19%，每股基本收益为0.05美元。机构评级：截至2024年8月16日，当前有8家机构对Tg Therapeutics, Inc.目标价做出预测，其中目标均价为33.75美元，其中最低目标价为8.00美元，最高目标价为49.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408160001329f2e430a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408160001329f2e430a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TGTX"],"gpt_icon":0},{"id":"1146587292","title":"异动解读 | TG Therapeutics股价大涨5.66% 生物技术行业表现抢眼","url":"https://stock-news.laohu8.com/highlight/detail?id=1146587292","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146587292?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:56","pubTimestamp":1723471016,"startTime":"0","endTime":"0","summary":"TG Therapeutics Inc.今日盘中股价大涨5.66%,引发市场关注。根据公开消息,该公司最新财报显示营收和净利润均有不错表现,每股收益0.05美元,毛利率也达到了65.09%。从行业层面来看,TG Therapeutics所在的生物技术行业今日整体表现较为抢眼,多只个股出现上涨。其中,Revance Therapeutics、Reviva Pharmaceuticals和Coeptis Therapeutics涨幅较大;Oragenics、Revance Therapeutics和60 Degrees Pharmaceuticals活跃度较高,换手率和振幅均处于较高水平。机构方面,78%的分析师给予TG Therapeutics\"买入\"评级,看好公司前景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TGTX"],"gpt_icon":0},{"id":"2458627986","title":"Tg Therapeutics, Inc.盘中异动 急速拉升5.17%报20.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458627986","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458627986?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:39","pubTimestamp":1723469940,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日21时39分，Tg Therapeutics, Inc.股票出现波动，股价大幅拉升5.17%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。其相关个股中，Revance Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，60 Degrees Pharmaceuticals, Inc.、Oragenics Inc.、Revance Therapeutics, Inc.较为活跃，换手率分别为53.00%、26.85%、22.95%，振幅较大的相关个股有Oragenics Inc.、Sangamo Therapeutics, Inc.、60 Degrees Pharmaceuticals, Inc.，振幅分别为30.36%、22.55%、21.44%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812213900aefe6b1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812213900aefe6b1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","TGTX","LENZ","BK4585","BK4139"],"gpt_icon":0},{"id":"2457484461","title":"Tg Therapeutics, Inc.盘中异动 快速拉升5.39%报21.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457484461","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457484461?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:31","pubTimestamp":1723037498,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日21时31分，Tg Therapeutics, Inc.股票出现异动，股价快速拉升5.39%。截至发稿，该股报21.69美元/股，成交量13.6387万股，换手率0.09%，振幅1.55%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807213138aefdba03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807213138aefdba03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","BK4585","LENZ","TGTX"],"gpt_icon":0},{"id":"1157651084","title":"异动解读 | TG Therapeutics上调多发性硬化症药物销售预期 股价大涨近21%","url":"https://stock-news.laohu8.com/highlight/detail?id=1157651084","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157651084?lang=zh_cn&edition=full","pubTime":"2024-08-06 22:35","pubTimestamp":1722954900,"startTime":"0","endTime":"0","summary":"制药公司TG Therapeutics(TGTX)今日股价在盘中大涨20.92%,引发市场广泛关注。这主要受到公司上调其多发性硬化症药物Briumvi 2024年销售预期的利好消息推动。\n\nTG Therapeutics将Briumvi 2024年产品净销售额预期从之前的2.7亿至2.9亿美元上调至2.9亿至3亿美元。这一调整反映了公司对该药物未来销售前景的乐观预期,增强了投资者对公司长期增长潜力的信心。\n\n除此之外,公司第二季度收入同比大幅增长,现金储备充裕,并设立了新的2.5亿美元信贷额度,为未来发展提供了资金支持。这些利好因素也在一定程度上推动了股价上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TGTX"],"gpt_icon":0},{"id":"1107481092","title":"异动解读 | TG Therapeutics上调多发性硬化症药物销售预期 股价大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1107481092","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107481092?lang=zh_cn&edition=full","pubTime":"2024-08-06 19:50","pubTimestamp":1722945015,"startTime":"0","endTime":"0","summary":"制药公司TG Therapeutics(TGTX)股价在盘前大涨19.06%,主要受到公司上调其多发性硬化症药物Briumvi 2024年销售预期的利好消息推动。\n\nTG Therapeutics将Briumvi 2024年产品净销售额预期从之前的2.7亿至2.9亿美元上调至2.9亿至3亿美元。这一调整反映了公司对该药物未来销售前景的乐观预期。\n\n此外,公司第二季度收入同比大幅增长,现金储备充裕,并设立了新的2.5亿美元信贷额度,为未来发展提供了资金支持。这些因素也在一定程度上推动了股价上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TGTX"],"gpt_icon":0},{"id":"2457434690","title":"BUZZ-TG Therapeutics上调其多发性硬化症药物的财政年度销售预期后，股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2457434690","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457434690?lang=zh_cn&edition=full","pubTime":"2024-08-06 19:46","pubTimestamp":1722944786,"startTime":"0","endTime":"0","summary":"    8月6日 - ** 制药商TG Therapeutics   股价盘前上涨17.6%至20.23美元 ** 该公司将其多发性硬化症药物Briumvi的2024年产品净销售额预期上调至2.9亿至3亿美元，而之前的预期区间为2.7亿至2.9亿美元。** 截至最后收盘，该公司股票今年以来基本持平","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4090","BK4139","BK4585","BUZZ","TGTX","BK4588","BK4153","TG","LENZ"],"gpt_icon":0},{"id":"2457730257","title":"Tg Therapeutics, Inc.盘中异动 股价大跌7.19%报17.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457730257","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457730257?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:36","pubTimestamp":1722865012,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时36分，Tg Therapeutics, Inc.股票出现异动，股价快速下挫7.19%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.68%。其相关个股中，Zevra Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Oculis Holding Ag C/Wts 06/03/2028 涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为1051.90%、47.05%、14.00%，振幅较大的相关个股有Alterity Therapeutics Limited、Cns Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.，振幅分别为20.00%、19.99%、17.59%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213652957f3119&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213652957f3119&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","TGTX","BK4585","BK4588"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tgtherapeutics.com","stockEarnings":[{"period":"1week","weight":0.1201},{"period":"1month","weight":0.4247},{"period":"3month","weight":0.4125},{"period":"6month","weight":1.0676},{"period":"1year","weight":1.7269},{"period":"ytd","weight":1.0228}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"TG Therapeutics, Inc.于1993年在特拉华州成立。该公司是一家完全整合、处于商业阶段的生物制药公司，专注于B细胞疾病新疗法的收购、开发和商业化。除了包括几种研究药物在内的一系列研究外，TG还获得了美国食品药品监督管理局（FDA）的BRIUMVI（ublituximab-xiiy）批准，用于治疗成人复发性多发性硬化症（RMS）患者，包括临床孤立综合征、复发缓解性疾病和活动性继发性进展性疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":0.055658},{"month":2,"riseRate":0.727273,"avgChangeRate":0.087019},{"month":3,"riseRate":0.636364,"avgChangeRate":0.095138},{"month":4,"riseRate":0.363636,"avgChangeRate":0.008444},{"month":5,"riseRate":0.545455,"avgChangeRate":0.017012},{"month":6,"riseRate":0.5,"avgChangeRate":0.057765},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.000866},{"month":8,"riseRate":0.583333,"avgChangeRate":-0.018713},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.054488},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.063094},{"month":11,"riseRate":0.916667,"avgChangeRate":0.190062},{"month":12,"riseRate":0.545455,"avgChangeRate":0.134525}],"exchange":"NASDAQ","name":"TG Therapeutics Inc.","nameEN":"TG Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TG Therapeutics Inc.(TGTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供TG Therapeutics Inc.(TGTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"TG Therapeutics Inc.,TGTX,TG Therapeutics Inc.股票,TG Therapeutics Inc.股票老虎,TG Therapeutics Inc.股票老虎国际,TG Therapeutics Inc.行情,TG Therapeutics Inc.股票行情,TG Therapeutics Inc.股价,TG Therapeutics Inc.股市,TG Therapeutics Inc.股票价格,TG Therapeutics Inc.股票交易,TG Therapeutics Inc.股票购买,TG Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TG Therapeutics Inc.(TGTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供TG Therapeutics Inc.(TGTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}